These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2689699)
1. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan]. Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699 [TBL] [Abstract][Full Text] [Related]
2. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection. Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Imaizumi M; Tada K; Aihara M; Sawada Y; Yokoyama M Tohoku J Exp Med; 1990 Oct; 162(2):183-93. PubMed ID: 2129071 [TBL] [Abstract][Full Text] [Related]
3. [The frequency of patients with positive HIV-antibody in the various groups and the prognosis of these patients treated with SNMC]. Endo Y; Mamiya S; Iwamoto K; Niitsu H; Itoh T; Miura A Rinsho Byori; 1990 Feb; 38(2):188-92. PubMed ID: 2329721 [TBL] [Abstract][Full Text] [Related]
4. Effects of glycyrrhizin (SNMC: stronger Neo-Minophagen C) in hemophilia patients with HIV infection. Mori K; Sakai H; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Seino Y; Ishida N; Uchida T; Kariyone S Tohoku J Exp Med; 1989 May; 158(1):25-35. PubMed ID: 2781539 [TBL] [Abstract][Full Text] [Related]
5. Pathological status and therapy of HIV-infected hemophiliacs in Japan. Yamada K Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():127-30. PubMed ID: 1363705 [TBL] [Abstract][Full Text] [Related]
6. AIDS studies in Japan. Harada S; Yamamoto N Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053 [TBL] [Abstract][Full Text] [Related]
7. High risk of acquired immune deficiency syndrome (AIDS) and of AIDS related complex (ARC) in hemophiliacs seropositive for more than 5 years. Stain C; Pabinger-Fasching I; Guggenberger K; Köller U; Stain M; Hartl H; Heinz F; Mayerhofer S; Kyrle PA; Lechner K Thromb Haemost; 1989 Jun; 61(3):354-6. PubMed ID: 2799750 [TBL] [Abstract][Full Text] [Related]
8. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients. Abe T AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637 [TBL] [Abstract][Full Text] [Related]
9. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029 [TBL] [Abstract][Full Text] [Related]
11. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Numazaki K; Umetsu M; Chiba S Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426 [TBL] [Abstract][Full Text] [Related]
12. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up. Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820 [TBL] [Abstract][Full Text] [Related]
13. [Detection of HIV-1 proviral DNA and RNA in serum from HIV-1 sero-positive hemophiliacs by polymerase chain reaction]. Horikoshi Y; Ichikawa M; Tonouchi T; Mimaya J; Morita T; Ohtsuka Y; Kawabata H Rinsho Ketsueki; 1993 May; 34(5):620-7. PubMed ID: 8315834 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression. Watanbe H; Miyaji C; Makino M; Abo T Biotherapy; 1996; 9(4):209-20. PubMed ID: 9012540 [TBL] [Abstract][Full Text] [Related]
15. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Hattori T; Ikematsu S; Koito A; Matsushita S; Maeda Y; Hada M; Fujimaki M; Takatsuki K Antiviral Res; 1989; 11(5-6):255-61. PubMed ID: 2572198 [TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
17. [Serum and immunological markers of progression to acquired immunodeficiency syndrome in hemophiliacs]. Navarro MD; Flores JM; Wichmann I; Rey C; Velardo MA; Pineda JA; Leal M; Lissen E Med Clin (Barc); 1989 Mar; 92(11):405-8. PubMed ID: 2786123 [TBL] [Abstract][Full Text] [Related]
18. Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex. Farthing CF; Dalgleish AG; Clark A; McClure M; Chanas A; Gazzard BG AIDS; 1987 May; 1(1):21-5. PubMed ID: 2962589 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and transmission of human immunodeficiency virus in Japan. Kurimura T; Kawatani T; Hattori N; Tsuchie H AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639 [TBL] [Abstract][Full Text] [Related]
20. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. Ragni MV; Ruben FL; Winkelstein A; Spero JA; Bontempo FA; Lewis JH J Lab Clin Med; 1987 May; 109(5):545-9. PubMed ID: 3572201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]